Maneesh Pharmaceuticals Limited

Maneesh Pharmaceuticals Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24230MH1985PLC036952 Incorporated 25 July 1985 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2022
₹534.48 Cr
▲ 28% YoY
Net profit · FY 2022
₹56.02 Cr
Net margin 10.5%
EBITDA · FY 2022
₹72.68 Cr
EBITDA margin 13.6%
Authorised capital
₹30 Cr
Registered with MCA
Paid-up capital
₹28.13 Cr
Issued & subscribed
Open charges
₹18 Cr
Satisfied ₹1,045.43 Cr
Company age
41 yrs
Est. 1985
Employees · EPFO
1,204
Provident fund records

About Maneesh Pharmaceuticals Limited

Data last updated:

Maneesh Pharmaceuticals Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 July 1985 and has been in existence for over 41 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1985PLC036952. Its GSTIN is 27AAACM3635Q1Z2 (Maharashtra). The company holds 16 GST registrations, of which 2 are active.

The company has an authorised share capital of ₹30 Cr and a paid-up capital of ₹28.13 Cr. It was formerly known as Maneesh Pharmaceuticals Private Limited and Maneesh Pharmaceuticals Pvt. Ltd. It is led by directors including Maneesh Ramakant Sapte (Whole-Time Director) and Ajit Gopal Jamkhandikar.

Its last annual general meeting (AGM) was held on 11 July 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 29/33 Ancillary Industrial Plots Govandi, Mumbai, Maharashtra, India – 400043.

As per the financials filed for FY 2022, the company reported a revenue of ₹534.48 Cr, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹56.02 Cr (net margin 10.5%) and EBITDA of ₹72.68 Cr (EBITDA margin 13.6%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 18% over five years.

The company has about 1,204 employees on its provident fund (EPFO) records. Its group structure includes 5 subsidiaries.

The company is associated with 1 brand: Maneesh Pharmaceuticals. As per MCA filings, the company has open charges of ₹18 Cr and satisfied charges of ₹1,045.43 Cr on record. Court records list 143 cases involving the company, including 77 filed by the company and 62 filed against it; 27 cases are pending. The company has 46 deals on record (37 secondary share transfers, 8 funding rounds, 1 rights issue), with disclosed funding of ₹158.95 Cr; the latest was in March 2022. Its 10 peer companies in the Pharma industry (Formulations, Pharmaceuticals) are compared by revenue, 5 larger and 5 smaller; the largest is German Remedies Pharmaceuticals Private Limited with revenue of ₹546.98 Cr. The company has 10 MSME Form 1 returns on record between 2019 and 2024, listing 688 overdue payments to 54 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website maneeshpharma.com.

Company Details of Maneesh Pharmaceuticals Limited
CIN U24230MH1985PLC036952
Registration Number 036952
Incorporation Date 25 July 1985
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 11 July 2023
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant

Name History of Maneesh Pharmaceuticals Limited

Maneesh Pharmaceuticals has undergone 2 name changes throughout its history. The company was previously known as Maneesh Pharmaceuticals Private Limited, and Maneesh Pharmaceuticals Pvt. Ltd.. The current legal name is Maneesh Pharmaceuticals Limited.

Company NameStatus
Maneesh Pharmaceuticals LimitedCurrent
Maneesh Pharmaceuticals Private LimitedPrevious
Maneesh Pharmaceuticals Pvt. Ltd.Previous

CIN History of Maneesh Pharmaceuticals Limited

Maneesh Pharmaceuticals has one previous CIN (Corporate Identification Number): U24230MH1985PTC036952. The current CIN is U24230MH1985PLC036952, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24230MH1985PLC036952Current
U24230MH1985PTC036952Previous
Key People
Maneesh Ramakant Sapte Whole-Time Director Rakesh Khetan Tunaram Cfo Ajit Gopal Jamkhandikar Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    maneeshpharma.com
  • Social Media
  • Registered Address
    29/33 Ancillary Industrial Plots Govandi, Mumbai, Maharashtra, India – 400043
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Maneesh Pharmaceuticals Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Maneesh Pharmaceuticals Limited report

Financials, compliance, directors, charges, ownership and filings for Maneesh Pharmaceuticals Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Associated Brands with Maneesh Pharmaceuticals Limited

Maneesh Pharmaceuticals operates one associated brand: Maneesh Pharmaceuticals. Each brand links to its own profile.

BrandDescriptionWebsite
Maneesh Pharmaceuticals
Branded formulations and generics are manufactured for therapeutic categories.maneeshpharma.com

Business Activity of Maneesh Pharmaceuticals Limited

The main business activity of Maneesh Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Maneesh Pharmaceuticals Limited FY 2023 filings available

Maneesh Pharmaceuticals Limited reported revenue of ₹534.48 Cr (up 28% YoY) for FY 2022.

Revenue · FY 2022
₹534.48 Cr ▲ 28%
Net profit · FY 2022
₹56.02 Cr margin 10.5%
EBITDA · FY 2022
₹72.68 Cr margin 13.6%

Compounded Annual Growth Rate (CAGR) of Maneesh Pharmaceuticals Limited

Revenue CAGR growth
1 year
▲ 28%
3 years · compounded
▲ 22%
5 years · compounded
▲ 18%
EBITDA CAGR growth
1 year
▲ 61%
3 years · compounded
▲ 45%
5 years · compounded
▼ 11%

Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 28% growth in the latest year. EBITDA rose 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Maneesh Pharmaceuticals Limited

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹72.68 Cr••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹56.02 Cr••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Maneesh Pharmaceuticals Limited

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profitability
EBITDA Margin13.6%••••••••••••••••
Net Profit Margin10.5%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Maneesh Pharmaceuticals are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors and KMP of Maneesh Pharmaceuticals Limited

Maneesh Pharmaceuticals Limited currently reports 5 directors and 1 key managerial person. 13 former directors have served the organization.

Current Directors and KMP
NameDesignationAppointment DateTenureStatus
Maneesh Ramakant Sapte
Also directs: Svizera Health Remedies LLP, Adhrit Education LLP, Phaarmasia Limited and 5 more
Whole-Time Director01 Oct 200224 Years 0 MonthsCurrent
Ajit Gopal Jamkhandikar
Also directs: Phaarmasia Limited
Director24 Aug 20188 Years 1 MonthsCurrent
Pravin Mohandas Hegde
Also directs: Phaarmasia Limited, Master Mind Property Private Limited
Director19 Jan 20179 Years 9 MonthsCurrent
Rakesh Khetan TunaramCfo20 Mar 201511 Years 7 MonthsCurrent
Rashmi Vinay Sapte
Also directs: Phaarmasia Limited, Zypcare Lifesciences Private Limited, Svizera Labs Private Limited and 3 more
Director30 Mar 200719 Years 6 MonthsCurrent
Vinay Ramakant Sapte
Also directs: Svizera Health Remedies LLP, Adhrit Education LLP, Phaarmasia Limited and 5 more
Director25 Jul 198541 Years 2 MonthsCurrent
View all directors and KMP

Peer Comparison of Maneesh Pharmaceuticals Limited

Maneesh Pharmaceuticals Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
German Remedies Pharmaceuticals Private Limited₹546.98 Cr (FY 2025)••••••••9.0%••••Ahmedabad, Gujarat, India
Graviti Pharmaceuticals Private Limited₹543.75 Cr (FY 2025)••••••••17.0%••••Hyderabad, Telangana, India
Hydra Active Pharma Sciences Private Limited₹542.62 Cr (FY 2021)••••••••165.0%••••Bangalore, Karnataka, India
Kusum Healthcare Private Limited₹537.89 Cr (FY 2025)••••••••10.0%••••New Delhi, Delhi, India
Unison Pharmaceuticals Private Limited₹537.1 Cr (FY 2025)••••••••23.0%••••Ahmedabad, Gujarat, India
Maneesh Pharmaceuticals Limited this company₹534.48 Cr (FY 2022)••••••••28.0%••••Mumbai, Maharashtra, India
Pharmed Limited₹528.59 Cr (FY 2025)••••••••8.0%••••Mumbai, Maharashtra, India
Mapaex Health and Personalcare Private Limited₹514.15 Cr (FY 2024)••••••••23.0%••••Bhopal, Madhya Pradesh, India
Flamingo Pharmaceuticals Limited₹508.5 Cr (FY 2025)••••••••14.0%••••Mumbai, Maharashtra, India
Mackinon Enterprises Private Limited₹504.87 Cr (FY 2025)••••••••58.0%••••Mumbai, Maharashtra, India
Cronus Pharma Specialities India Private Limited₹484.74 Cr (FY 2025)••••••••64.0%••••Hyderabad, Telangana, India

Peers are the five companies nearest above and the five nearest below Maneesh Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Maneesh Pharmaceuticals Limited

Maneesh Pharmaceuticals Limited is audited by M. M. NISSIM & Co. for the financial year 2021.

NameStatusAppointment DateCessation Date
M. M. NISSIM & Co.LockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Maneesh Pharmaceuticals Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Maneesh Pharmaceuticals Limited

Open charges
₹18 Cr
Satisfied charges
₹1,045.43 Cr
Breakdown by lending institutions
Export-Import Bank of India₹18.00 Cr
Latest charge details
DateLenderAmountStatus
19 Jul 2004Export-Import Bank of India₹18 CrOpen
28 Dec 2011Pegasus Group Twenty Six Trust - I- Pegasus Assets Reconstruction Private Limited₹110.58 CrSatisfied
18 Feb 2011Icici Bank Limited₹18.5 CrSatisfied
05 Mar 2010Pegasus Group Twenty Six Trust - I- Pegasus Assets Reconstruction Private Limited₹10 CrSatisfied
11 Oct 20083I Infotech Trusteeship Services Limited₹25 CrSatisfied

Total charge records: 36 View all charges

Deals & Funding of Maneesh Pharmaceuticals Limited

Maneesh Pharmaceuticals Limited has 46 deals on record (37 secondary share transfers, 8 funding rounds, 1 rights issue), with disclosed funding of ₹158.95 Cr; the latest was in March 2022.

Total deals
46
Secondary share transfers
37
Funding rounds
8
Rights issue
1
Disclosed funding
₹158.95 Cr

Deals on record (5 of 46)

WhenDealAmountParties
Mar 2022Secondary share transferUndisclosedBuyer: Chanakya Corporate Services Private Limited
Seller: Calculas Financial Consultants Privnate Limited
Jan 2021Secondary share transferUndisclosedBuyer: Calculas Financial Consultants Privnate Limited
Seller: Chanakya Corporate Services Private Limited
Mar 2015Rights issue₹18.75 CrInvestors: 4 individuals
Mar 2014Secondary share transferUndisclosedBuyer: Sarvamangal Mercantile Co.Limited, 3 individuals
Seller: Oricon Properties Private Limited , 3 individuals
May 2013Funding round₹12.5 CrInvestors: 4 individuals
Premium access

Full deal history

All 46 deals with amounts, valuations, instruments and every party are in the company report.

  • Every funding round and share transfer
  • Amounts and valuations
  • Investors, buyers and sellers
  • Instruments and deal dates

Verified entity values are shown only after access is granted.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME Payment Delays by Maneesh Pharmaceuticals Limited

Maneesh Pharmaceuticals Limited has 10 MSME Form 1 returns on record between 2019 and 2024, listing 688 overdue payments to 54 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 54)

SupplierAmount dueDue sinceReported on
Pontika Aerotech Limited••••••••••••
an individual supplier••••••••••••
Raj Enterprises••••••••••••
Pure Impressions Printech Private Limited••••••••••••
S.S.Enterprises••••••••••••
Premium access

Full MSME payment history

Every supplier, amount and due date from all 10 MSME Form 1 returns is in the company report.

  • Every reported supplier due
  • Amounts and due dates
  • Reasons given in each return
  • Period-by-period history

Verified entity values are shown only after access is granted.

Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.

Employees and EPFO Compliance at Maneesh Pharmaceuticals Limited

Maneesh Pharmaceuticals Limited has a workforce of 1,204 employees as of Feb 27, 2025.

Employee count
1,204
Active EPFO establishments
4
Employee growth
-1.31%
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Group Structure of Maneesh Pharmaceuticals Limited

Maneesh Pharmaceuticals has 5 subsidiary companies and 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

5
Subsidiary companies
1
Associated companies
Key Subsidiaries
Company NameCINShares Held
Phaarmasia LimitedL24239TG1981PLC002915Locked
Pharmanova Specialties Private LimitedU24233MH2014PTC252718Locked
Ergos Life Sciences Private LimitedU24303MH2017PTC292787Locked
Svizera Labs Private LimitedU74999MH1997PTC107389Locked
Shanbag Storage And Services Private LimitedU74999MH2010PTC201092Locked

Showing major subsidiaries. Total: 5.

Recent Activity on Maneesh Pharmaceuticals Limited

Maneesh Pharmaceuticals Limited has 14 board changes on record since 1985: 6 appointments and 8 cessations. The latest: Maneesh Ramakant Sapte ceased to be Director on 31 Mar 2023.

AGM
Maneesh Pharmaceuticals Limited last Annual general meeting of members was held on 11 Jul 2023 as per latest MCA records.
Filing
Maneesh Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
Ceased
Maneesh Ramakant Sapte ceased to be Director.
Ceased
Vinay Ramakant Sapte ceased to be Managing Director.
Charges
A charge registered on 03 Jun 2008 via Charge ID 10151826 with Il & Fs Trust Company Limited was fully satisfied on 14 Jul 2022.
Charges
A charge registered on 13 Dec 2007 via Charge ID 10080716 with Others was fully satisfied on 12 Jul 2022.
Charges
A charge registered on 15 Nov 2000 via Charge ID 80067094 with Alchemist Asset Reconstruction Company Limited was fully satisfied on 12 Jul 2022.
Ceased
Ajit Gopal Jamkhandikar ceased to be Additional Director.
Appointed
Ajit Gopal Jamkhandikar was appointed as Director.
Ceased
Bharat Bachubai Merchant ceased to be Director.
Ceased
Pravin Mohandas Hegde ceased to be Additional Director.
Charges
A charge registered on 14 Jun 2004 via Charge ID 80047138 with Standard Chartered Bank was fully satisfied on 24 Jan 2017.

88 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Maneesh Pharmaceuticals Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Maneesh Pharmaceuticals Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Maneesh Pharmaceuticals Limited

Maneesh Pharmaceuticals has 16 GST registrations: 2 active and 14 cancelled or inactive.

Total GSTINs
16
Active
2
Cancelled / inactive
14
GSTINStateStatusRegistered on
27AAACM3635Q1Z2MaharashtraActive01 Jul 2017
02AAACM3635Q1ZEHimachal PradeshActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Maneesh Pharmaceuticals Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Maneesh Pharmaceuticals Limited

Maneesh Pharmaceuticals is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 July 1985 (41+ years old) and is registered under CIN U24230MH1985PLC036952.

Maneesh Pharmaceuticals reported revenue of ₹534.48 Cr for FY 2022 (up 28% YoY).

Maneesh Pharmaceuticals has 6 current directors and KMP:

Maneesh Pharmaceuticals reported a net profit of ₹56.02 Cr (net margin 10.5%) and EBITDA of ₹72.68 Cr (EBITDA margin 13.6%) for FY 2022, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Maneesh Pharmaceuticals is 22% over three years and 18% over five years. In the latest year (FY 2022) revenue rose 28%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Maneesh Pharmaceuticals is 27AAACM3635Q1Z2, registered in Maharashtra. The company has 16 GST registrations in all, of which 2 are active and 14 are cancelled or inactive. Other active GSTINs include 02AAACM3635Q1ZE (Himachal Pradesh).

The CIN (Corporate Identification Number) of Maneesh Pharmaceuticals is U24230MH1985PLC036952. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Maneesh Pharmaceuticals has 143 court cases on record: 77 filed by the company and 62 filed against it. 27 are pending. Most are in the high courts.

Maneesh Pharmaceuticals was incorporated on 25 July 1985, making it 41+ years old. It is registered with the Registrar of Companies, Mumbai.

Maneesh Pharmaceuticals has 46 deals on record (37 secondary share transfers, 8 funding rounds, 1 rights issue), with disclosed funding of ₹158.95 Cr; the latest was in March 2022.

The peers of Maneesh Pharmaceuticals by revenue are German Remedies Pharmaceuticals Private Limited, Graviti Pharmaceuticals Private Limited, Hydra Active Pharma Sciences Private Limited, Kusum Healthcare Private Limited, Unison Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).

Maneesh Ramakant Sapte ceased to be Director on 31 Mar 2023. Vinay Ramakant Sapte ceased to be Managing Director on 31 Mar 2023. Ajit Gopal Jamkhandikar ceased to be Additional Director on 18 Sep 2018. Maneesh Pharmaceuticals has 14 board changes on record in total.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available